Posted 3/4/2024, 12:30:00 PM
Vocal Biomarker Market to Reach $3.4 Billion by 2028, Driven by Growth in AI and Telemedicine for Chronic Disease Diagnosis
- Global vocal biomarker market projected to grow at 9.32% CAGR from 2022-2028, reaching $3.41 billion by 2028
- Key drivers are rising chronic disease prevalence and AI advancements enabling vocal analysis
- Growing application in neurological disorder diagnosis through non-invasive speech pattern monitoring
- Telemedicine and respiratory monitoring identified as trending vocal biomarker use cases
- North America leads market share currently; frequency analysis is the dominant technique